These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 28476099

  • 1. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
    Kawakami K, Fujita Y, Matsuda Y, Arai T, Horie K, Kameyama K, Kato T, Masunaga K, Kasuya Y, Tanaka M, Mizutani K, Deguchi T, Ito M.
    BMC Cancer; 2017 May 05; 17(1):316. PubMed ID: 28476099
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.
    Prostate; 2003 Mar 01; 54(4):249-57. PubMed ID: 12539223
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Integrin β4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane-resistance.
    Kawakami K, Fujita Y, Kato T, Mizutani K, Kameyama K, Tsumoto H, Miura Y, Deguchi T, Ito M.
    Int J Oncol; 2015 Jul 01; 47(1):384-90. PubMed ID: 25997717
    [Abstract] [Full Text] [Related]

  • 8. [Clinical significance of expression of PSA, hK2, PSMA in the peripheral blood of patients with prostate cancer].
    Cui WG, Zhao H, Song YZ, Zhang J, Zhang LG, Shi JD, Qiang WM.
    Zhonghua Zhong Liu Za Zhi; 2004 Aug 01; 26(8):479-81. PubMed ID: 15555338
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer.
    Kato T, Mizutani K, Kameyama K, Kawakami K, Fujita Y, Nakane K, Kanimoto Y, Ehara H, Ito H, Seishima M, Deguchi T, Ito M.
    Urol Oncol; 2015 Sep 01; 33(9):385.e15-20. PubMed ID: 26027763
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer.
    Murphy GP, Kenny GM, Ragde H, Wolfert RL, Boynton AL, Holmes EH, Misrock SL, Bartsch G, Klocker H, Pointner J, Reissigl A, McLeod DG, Douglas T, Morgan T, Gilbaugh J.
    Urology; 1998 May 01; 51(5A Suppl):89-97. PubMed ID: 9610563
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.
    Kharmate G, Hosseini-Beheshti E, Caradec J, Chin MY, Tomlinson Guns ES.
    PLoS One; 2016 May 01; 11(5):e0154967. PubMed ID: 27152724
    [Abstract] [Full Text] [Related]

  • 17. Alteration in gamma-glutamyl transpeptidase activity and messenger RNA of human prostate carcinoma cells by androgen.
    Ripple MO, Pickhardt PA, Wilding G.
    Cancer Res; 1997 Jun 15; 57(12):2428-33. PubMed ID: 9192821
    [Abstract] [Full Text] [Related]

  • 18. Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo.
    Severic M, Ma G, Pereira SGT, Ruiz A, Cheung CCL, Al-Jamal WT.
    J Control Release; 2021 Feb 10; 330():101-110. PubMed ID: 33333118
    [Abstract] [Full Text] [Related]

  • 19. Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
    Worst TS, von Hardenberg J, Gross JC, Erben P, Schnölzer M, Hausser I, Bugert P, Michel MS, Boutros M.
    Mol Cell Proteomics; 2017 Jun 10; 16(6):998-1008. PubMed ID: 28396511
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.